| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kerstin Alexandra Klotz, Jan Schönberger, Lea Nakamura, Victoria San Antonio-Arce, Thomas Bast, Adelheid Wiemer-Kruel, Susanne Schubert-Bast, Ingo Borggraefe, Steffen Syrbe, Julia Jacob. Expectations and knowledge of cannabidiol therapy for childhood epilepsy - A German caregiver survey. Epilepsy & behavior : E&B. vol 111. 2021-03-17. PMID:32645621. |
expectations and knowledge of cannabidiol therapy for childhood epilepsy - a german caregiver survey. |
2021-03-17 |
2023-08-13 |
Not clear |
| Matthew D Thompson, Roy C Martin, Leslie P Grayson, Steve B Ampah, Gary Cutter, Jerzy P Szaflarski, E Martina Bebi. Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 111. 2021-03-17. PMID:32759071. |
cognitive function and adaptive skills after a one-year trial of cannabidiol (cbd) in a pediatric sample with treatment-resistant epilepsy. |
2021-03-17 |
2023-08-13 |
Not clear |
| Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome). Australian prescriber. vol 44. issue 1. 2021-03-06. PMID:33664547. |
cannabidiol for epilepsy (lennox-gastaut syndrome, dravet syndrome). |
2021-03-06 |
2023-08-13 |
Not clear |
| Lily Goodyer Sait, Altin Sula, Mohammad-Reza Ghovanloo, David Hollingworth, Peter C Ruben, B A Wallac. Cannabidiol interactions with voltage-gated sodium channels. eLife. vol 9. 2021-03-03. PMID:33089780. |
cannabidiol (cbd), the non-psychoactive compound isolated from cannabis plants, was recently approved for treatment of two types of epilepsy associated with sodium channel mutations. |
2021-03-03 |
2023-08-13 |
Not clear |
| Rafael M Bitencourt, Reinaldo N Takahashi, Elisaldo A Carlin. From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders? Frontiers in psychiatry. vol 12. 2021-03-03. PMID:33643100. |
from an alternative medicine to a new treatment for refractory epilepsies: can cannabidiol follow the same path to treat neuropsychiatric disorders? |
2021-03-03 |
2023-08-13 |
Not clear |
| Jesse Elliott, Deirdre DeJean, Beth K Potter, Doug Coyle, Tammy Clifford, Bláthnaid McCoy, George A Well. Neurologists' perspectives on medical cannabis for pediatric drug-resistant epilepsy in Canada: A qualitative interview study. Seizure. vol 78. 2021-02-26. PMID:32361185. |
neurologists' perspectives on medical cannabis for pediatric drug-resistant epilepsy in canada: a qualitative interview study. |
2021-02-26 |
2023-08-13 |
Not clear |
| Jesse Elliott, Deirdre DeJean, Beth K Potter, Doug Coyle, Tammy Clifford, Bláthnaid McCoy, George A Well. Neurologists' perspectives on medical cannabis for pediatric drug-resistant epilepsy in Canada: A qualitative interview study. Seizure. vol 78. 2021-02-26. PMID:32361185. |
to understand the experiences with and perspectives of neurologists about the use of medical cannabis in the treatment of pediatric drug-resistant epilepsy. |
2021-02-26 |
2023-08-13 |
Not clear |
| Victoria Golub, D Samba Redd. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Advances in experimental medicine and biology. vol 1264. 2021-02-03. PMID:33332006. |
cannabidiol therapy for refractory epilepsy and seizure disorders. |
2021-02-03 |
2023-08-13 |
Not clear |
| Victoria Golub, D Samba Redd. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Advances in experimental medicine and biology. vol 1264. 2021-02-03. PMID:33332006. |
recently, there has been emerging interest in the use of cannabidiol (cbd)-enriched products for treatment of drug-resistant epilepsy. |
2021-02-03 |
2023-08-13 |
Not clear |
| Victoria Golub, D Samba Redd. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Advances in experimental medicine and biology. vol 1264. 2021-02-03. PMID:33332006. |
this chapter briefly describes the current information on cannabis pharmacology with an emphasis on the clinical utility of cbd in the treatment of refractory epilepsies and other related seizure conditions. |
2021-02-03 |
2023-08-13 |
Not clear |
| Magdalena Szaflarski, Patricia McGoldrick, Lauryn Currens, Dustin Blodgett, Hunter Land, Jerzy P Szaflarski, Eric Sega. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists. Epilepsy & behavior : E&B. vol 109. 2021-02-01. PMID:32442891. |
over 80% of participants supported use and legalization of medical cannabis, especially cannabidiol (cbd) for epilepsy and when prescribed by a medical provider, but 40-50% (depending on item) felt unfamiliar with cannabinoid pharmacology and clinical applications. |
2021-02-01 |
2023-08-13 |
human |
| Nancy A McNamara, Louis T Dang, Julie Sturza, Julie M Ziobro, Erin M Fedak Romanowski, Garnett C Smith, Sucheta M Joshi, Steven M Leber, Martha Carlson, Patricia Robertson, Renée A Shellhaa. Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid. Epilepsia. vol 61. issue 8. 2021-01-22. PMID:32614070. |
we evaluated salient features of the patients' epilepsy syndrome, age, concurrent medications, and surveillance laboratory results before and after cannabidiol initiation. |
2021-01-22 |
2023-08-13 |
Not clear |
| David E Mandelbau. Re: Efficacy of Cannabidiol in Subjects with Refractory Epilepsy Relative to Concomitant Use of Clobazam. Epilepsy research. 2021-01-12. PMID:32051101. |
re: efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam. |
2021-01-12 |
2023-08-13 |
human |
| Luisa Rocha, Christian Lizette Frías-Soria, José G Ortiz, Jerónimo Auzmendi, Alberto Lazarowsk. Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? Epilepsia open. vol 5. issue 1. 2021-01-10. PMID:32140642. |
is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? |
2021-01-10 |
2023-08-13 |
Not clear |
| Luisa Rocha, Christian Lizette Frías-Soria, José G Ortiz, Jerónimo Auzmendi, Alberto Lazarowsk. Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? Epilepsia open. vol 5. issue 1. 2021-01-10. PMID:32140642. |
cannabis has been considered as a therapeutic strategy to control intractable epilepsy. |
2021-01-10 |
2023-08-13 |
Not clear |
| Willian Lazarini-Lopes, Raquel A Do Val-da Silva, Rui M P da Silva-Júnior, João P Leite, Norberto Garcia-Cairasc. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights. Neuroscience and biobehavioral reviews. vol 111. 2021-01-05. PMID:31954723. |
in this context, cannabidiol (cbd), a non-psychoactive phytocannabinoid present in cannabis, has been a promising compound for treating epilepsies due to its anticonvulsant properties in animal models and humans, especially in pharmacoresistant patients. |
2021-01-05 |
2023-08-13 |
human |
| Sara Dubois, Francesca Marchese, Federica Pigliasco, Sebastiano Barco, Gino Tripodi, Tommaso Lomonaco, Simona Lattanzi, Emilio Russo, Giuliana Cangemi, Pasquale Strian. A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients. Frontiers in pharmacology. vol 11. 2020-12-31. PMID:33364956. |
a volumetric absorptive microsampling technique to monitor cannabidiol levels in epilepsy patients. |
2020-12-31 |
2023-08-13 |
Not clear |
| David E Anderson, Deepak Madhavan, Arun Swaminatha. Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy. Brain communications. vol 2. issue 2. 2020-12-31. PMID:33376981. |
global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy. |
2020-12-31 |
2023-08-13 |
Not clear |
| David E Anderson, Deepak Madhavan, Arun Swaminatha. Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy. Brain communications. vol 2. issue 2. 2020-12-31. PMID:33376981. |
refractory epilepsy patients with lennox gastaut syndrome or dravet syndrome underwent serial electroencephalography testing prior to and during cannabidiol treatment. |
2020-12-31 |
2023-08-13 |
Not clear |
| David E Anderson, Deepak Madhavan, Arun Swaminatha. Global brain network dynamics predict therapeutic responsiveness to cannabidiol treatment for refractory epilepsy. Brain communications. vol 2. issue 2. 2020-12-31. PMID:33376981. |
in summary, we demonstrate novel effects of cannabidiol on brain network dynamics with important implications for the treatment of refractory epilepsy and, possibly, across broader research applications in the future. |
2020-12-31 |
2023-08-13 |
Not clear |